Sen. Bernie Sanders (I-Vt.) has taken a stand against the “outrageous” prices of diabetes drug Ozempic by Novo Nordisk (NYSE:NVO). He is considering hearings on the issue and is seeking a meeting with the company’s CEO to discuss reducing the drug’s price. What Happened: Sanders, who chairs the Senate Health, Education, Labor, and Pensions (HELP) Committee, is concerned about the high cost of Ozempic. Ozempic is sometimes used controversially for weight loss by suppressing appetite. He plans to meet with ‘Miracle’ weight loss drug maker’s CEO, Lars Fruergaard Jørgensen, to discuss lowering the…
